Health Ministry Expands QR Code Drug Traceability to Vaccines, Antimicrobials

The Ministry of Health has announced significant amendments to the Drugs Rules, expanding the pharmaceutical track-and-trace system to include vaccines, anti-cancer medications, antimicrobials, and NDPS drugs under Schedule H2. Implementation begins July 2027 with a phased approach. This regulatory evolution addresses critical public health objectives: (1) Combating counterfeit medicines, particularly vaccines and cancer drugs—categories with highest fake medicine prevalence; (2) Antimicrobial resistance tracking and surveillance; (3) NDPS drug diversion prevention. QR-code enabled traceability ensures supply-chain transparency from manufacturer to patient. Background: India experiences estimated 10-20% counterfeit drug circulation; vaccines and oncology drugs command premium prices, making them high-counterfeit targets. The move aligns with WHO guidelines and India's Digital India initiative. Key impacts: (1) Pharmaceutical industry compliance costs, (2) Enhanced patient safety, (3) Regulatory monitoring capability, (4) Data-driven epidemiology. For UPSC: Connects to (1) Public health governance, (2) Regulatory frameworks for pharmaceuticals, (3) Digital authentication technologies, (4) Antimicrobial resistance as global health threat, (5) Supply chain integrity in critical medicines.